Abstract
The authors present some observations regarding the use of topical anti-glaucoma therapy and systemic vasodilators.
Material and methods:
The study was carried out on a series of 996 glaucoma patients, of which 54.1% with primary open-angle glaucoma, 5.7% closed-angle glaucoma, and 17.6% with normal intraocular pressure.
Results:
Intraocular pressure and visual field were assessed after the use of such therapeutic methods as carbonic anhydrase inhibitors (dorzolamide) and prostaglandin (latanoprost) and dorzolamide (cosopt) association.
Conclusions:
The favorable progression of glaucoma could be improved by using new etiopathogenic mechanisms and treatment approaches.
MeSH terms
-
Antihypertensive Agents / administration & dosage*
-
Carbonic Anhydrase Inhibitors / administration & dosage
-
Drug Therapy, Combination
-
Follow-Up Studies
-
Glaucoma, Angle-Closure / drug therapy*
-
Glaucoma, Angle-Closure / physiopathology
-
Glaucoma, Open-Angle / drug therapy*
-
Glaucoma, Open-Angle / physiopathology
-
Humans
-
Intraocular Pressure / drug effects*
-
Latanoprost
-
Ocular Hypertension / drug therapy
-
Ophthalmic Solutions / administration & dosage
-
Prostaglandins F, Synthetic / administration & dosage*
-
Retrospective Studies
-
Sulfonamides / administration & dosage*
-
Thiophenes / administration & dosage*
-
Treatment Outcome
-
Visual Fields / drug effects*
Substances
-
Antihypertensive Agents
-
Carbonic Anhydrase Inhibitors
-
Ophthalmic Solutions
-
Prostaglandins F, Synthetic
-
Sulfonamides
-
Thiophenes
-
Latanoprost
-
dorzolamide